Medically Prescribed Apps Market? Global Industry Analysis, Size, Share, Growth,

Posted by ashutosh kalbande on March 1st, 2019

Market Research Future (MRFR) has announced a new report on the Global Medically Prescribed Apps Market. The report provides readers with an intricate overview of the global medically prescribed apps market based on a solid review of the market’s historical growth patterns.

 The major growth drivers and restraints of the global medically prescribed apps market are also analyzed in the report, which estimates the market to grow at a CAGR of around 18.8% over the forecast period from 2017 to 2027.

Medically prescribed apps are apps that help physicians monitor patient health remotely and allow patients to contact physicians in case of emergencies as well as getting information about their disease and information about the nearest physicians in any location. The apps also collect medical data about the patient’s condition and share it with physicians, allowing the latter to gain a comprehensive overview of the patient’s present conditions at a glance. The efficient, reliable, and convenient usability of medically prescribed apps is likely to drive their usage over the forecast period. Medically prescribed apps provide accurate and comprehensive information in a single go, besides being a highly convenient medium between patients and physicians.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/752

The growing prevalence of chronic conditions that require long-term monitoring rather than urgent treatment is likely to be a major driver for the global medically prescribed apps market over the forecast period. Conditions such as diabetes, chronic cardiovascular diseases, and even cancer need to be monitored constantly, but apart from periodic visits, there is little need for the patient to remain in the hospital. Thus, medically prescribed apps have emerged as a promising solution for such diseases, as they allow patients or their loved ones to monitor the disease in a homecare setting, on top of the scheduled physician visits and medications.

Competitive Analysis:

Leading players in the Global Medically Prescribed Apps Market include Pathfinder International, Fueled, WillowTree Inc., OpenXcell, Contus, Savvy Apps, Intellectsoft US, ArcTouch, Y Media Labs, Sourcebits Technologies, and InnovationM.

Industry Updates:

In November 2018, AliveCor demonstrated a heart attack detection app at the 2018 American Heart Association’s Scientific Sessions. The app requires users to purchase two wireless electrical leads, and can detect ST segment elevation myocardial infarction, called STEMI, with nearly as much efficacy as a hospital-based ECG system.

Segmentation:

The Global Medically Prescribed Apps Market is segmented on the basis of type, device, application, operating system, and region.

On the basis of type, the global medically prescribed apps market is segmented into wellness management apps, diseases and treatment management apps, disease-specific apps, women’s health and pregnancy apps, and others.

On the basis of device, the market is segmented into smartphones, personal digital assistants (PDAs), tablet computers, and others.

By application, the medically prescribed apps market is segmented into cardiac monitoring, diabetes management, multi-parameter tracking, and others.

By operating system, the medically prescribed apps market is segmented into Windows, Android, iOS, and others.

Browse Full Reports @ https://www.marketresearchfuture.com/reports/medically-prescribed-apps-market-752

Regional Analysis:

The Global Medically Prescribed Apps Market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa on the basis of region.

The Americas, dominated by North America, is likely to emerge as the leading regional segment of the global medically prescribed apps market over the forecast period. The region held a dominant share of 47% in the global medically prescribed apps market in 2016 and is likely to witness a steady rise in its share in the market over the forecast period due to the growing prevalence of chronic conditions that require long-term monitoring, and the increasing acceptance of medically prescribed apps from physicians and patients alike. The unhealthy dietary and lifestyle choices of consumers in the region are likely to lead to further growth in the prevalence of diseases such as diabetes and cardiovascular conditions, lending further impetus to the medically prescribed apps market in the region.

Asia Pacific could exhibit robust growth in the medically prescribed apps market over the forecast period due to the growing smartphone usage as well as the growing prevalence of diabetes and cancer.